The patent is related to the devicemaker’s ZipFlex technology for a minimally invasive posterior interlaminar implant, according to a June 13 news release. It is designed for a minimally invasive posterior interlaminar implant for motion preservation that could be adapted into a fusion or non-fusion device.
Features of ZipFlex include individually adjustable anchors to prevent implant migration and unnecessary bone removal to fit the implant. It’s the first technology to have an all-in-one approach for treating back pain.
Aurora Spine previously got a notice of allowance for the patent in February.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.